Evidence for antibody as a protective correlate for COVID-19 vaccines

A correlate of protection (CoP) is urgently needed to expedite development of additional COVID-19 vaccines to meet unprecedented global demand. To assess whether antibody titers may reasonably predict efficacy and serve as the basis of a CoP, we evaluated the relationship between efficacy and in vit...

Descripción completa

Detalles Bibliográficos
Autores principales: Earle, Kristen A., Ambrosino, Donna M., Fiore-Gartland, Andrew, Goldblatt, David, Gilbert, Peter B., Siber, George R., Dull, Peter, Plotkin, Stanley A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Science 2021
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142841/
https://www.ncbi.nlm.nih.gov/pubmed/34210573
http://dx.doi.org/10.1016/j.vaccine.2021.05.063

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8142841/
https://www.ncbi.nlm.nih.gov/pubmed/34210573
http://dx.doi.org/10.1016/j.vaccine.2021.05.063

Ejemplares similares